(Q42242321)

19 October 2017

title

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study (English)

1 reference

Japanese encephalitis virus

19 October 2017

main subject

0 references

Japanese encephalitis

1 reference

1 reference

8

1 reference

19 October 2017

Elina O Erra

1

1 reference

19 October 2017

Helena Hervius Askling

2

1 reference

19 October 2017

Sutee Yoksan

3

1 reference

19 October 2017

Lars Rombo

4

1 reference

19 October 2017

Jukka Riutta

5

1 reference

19 October 2017

Sirkka Vene

6

1 reference

19 October 2017

Lars Lindquist

7

1 reference

19 October 2017

Anu Kantele

9

1 reference

19 October 2017

language of work or name

English

0 references

publication date

28 October 2013

1 reference

19 October 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 October 2017

volume

32

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

119-123

1 reference

Control of Japanese encephalitis--within our grasp?

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Japanese encephalitis: update on vaccines and vaccine recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Change in Japanese Encephalitis Virus Distribution,Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.055

10.1016/J.VACCINE.2013.10.055

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference